Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06336395 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ma-Spore ALL 2020 Study

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The primary objective of this trial is to improve the overall survival rate of children and young adult with B-lineage acute lymphoblastic leukemia (B-ALL) in Singapore and Malaysia in the context of a multicenter cooperative trial using a risk-stratified therapy.
Trial Details
NCT Number NCT06336395
Lead Sponsor National University Hospital, Singapore
Conditions
(from sponsor)		 B Lymphoblastic Leukemia
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov